Immunomodulating effects of endotoxin in mouse models of allergic asthma

Clinical and Experimental Allergy

Volumn 40, Issue 4, 2010, Pages 536-546

  Zhu, Z ^a   Oh, S Y ^a   Zheng, T ^a   Kim, Y K ^b  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ENDOTOXIN; LIPOPOLYSACCHARIDE; OVALBUMIN;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ATOPY; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIZATION; TH2 CELL; WHEEZING;

ALLERGENS; ANIMALS; ASTHMA; ENDOTOXINS; HUMANS; HYPERSENSITIVITY; LIPOPOLYSACCHARIDES; MICE;

EID: 77949415690     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03477.x     Document Type: Review

References (67)

1. Cutz E, Levison H, Cooper DM. Ultrastructure of airways in children with asthma. Histopathology 1978; 2:407-21.
2. Bochner BS, Undem BJ, Lichtenstein LM. Immunological aspects of allergic asthma. Annu Rev Immunol 1994; 12:295-335.
3. ten Hacken NH, Oosterhoff Y, Kauffman HF et al. Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur Respir J 1998; 11:312-6.
4. Shannon J, Ernst P, Yamauchi Y et al. Martin JG, Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008; 133:420-6.
5. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11:54-61.
6. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008; 372:1107-19.
7. Gibson PG. Tackling asthma phenotypes in community studies. Thorax 2009; 64:369-70.
8. Braun-Fahrlander C, Riedler J, Herz U et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869-77.
9. Michel O, Ginanni R, Duchateau J, Vertongen F, Le Bon B, Sergysels R. Domestic endotoxin exposure and clinical severity of asthma. Clin Exp Allergy 1991; 21:441-8.
10. Michel O, Kips J, Duchateau J et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154:1641-6.
11. Thorne PS, Kulhánková K, Yin M, Cohn R, Arbes SJJ, Zeldin DC. Endotoxin exposure is a risk factor for asthma: the national survey of endotoxin in United States housing. Am J Respir Crit Care Med 2005; 172:1371-7.
12. Tavernier G, Fletcher G, Gee I et al. IPEADAM study: indoor endotoxin exposure, family status, and some housing characteristics in english children. J Allergy Clin Immunol 2006; 117:656-62.
13. Horick N, Weller E, Milton DK, Gold DR, Li R, Spiegelman D. Home endotoxin exposure and wheeze in infants: correction for bias due to exposure measurement error. Environ Health Perspect 2006; 114:135-40.
14. Celedón JC, Milton DK, Ramsey CD et al. Exposure to dust mite allergen and endotoxin in early life and asthma and atopy in childhood. J Allergy Clin Immunol 2007; 120:144-9.
15. Rennie DC, Lawson JA, Kirychuk SP et al. Assessment of endotoxin levels in the home and current asthma and wheeze in school-age children. Indoor Air 2008; 18:447-53.
16. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5:337-43.
17. Park JH, Gold DR, Spiegelman DL, Burge HA, Milton DK. House dust endotoxin and wheeze in the first year of life. Am J Respir Crit Care Med 2001; 163:322-8.
18. Hogg JC. Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 1999; 160:S26-8.
19. Bisgaard H, Hermansen MN, Buchvald F et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487-95.
20. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2007; 62:211-8.
21. Kennedy SM, Christiani DC, Eisen EA et al. Cotton dust and endotoxin exposure-response relationships in cotton textile workers. Am Rev Respir Dis 1987; 135:194-200.
22. Schwartz DA, Thorne PS, Yagla SJ et al. The role of endotoxin in grain dust-induced lung disease. Am J Respir Crit Care Med 1995; 152:603-8.
23. Milton DK, Wypij D, Kriebel D, Walters MD, Hammond SK, Evans JS. Endotoxin exposure-response in a fiberglass manufacturing facility. Am J Ind Med 1996; 29:3-13.
24. Monn C, Becker S. Cytotoxicity and induction of proinflammatory cytokines from human monocytes exposed to fine (PM2.5) and coarse particles (PM10-2.5) in outdoor and indoor air. Toxicol Appl Pharmacol 1999; 155:245-52.
25. Soukup JM, Becker S. Human alveolar macrophage responses to air pollution particulates are associated with insoluble components of coarse material, including particulate endotoxin. Toxicol Appl Pharmacol 2001; 171:20-6.
26. Alexis NE, Lay JC, Zeman K et al. Biological material on inhaled coarse fraction particulate matter activates airway phagocytes in vivo in healthy volunteers. J Allergy Clin Immunol 2006; 117:1396-403.
27. Rylander R, Bake B, Fischer JJ, Helander IM. Pulmonary function and symptoms after inhalation of endotoxin. Am Rev Respir Dis 1989; 140:981-6.
28. Zhiping W, Malmberg P, Larsson BM, Larsson K, Larsson L, Saraf A. Exposure to bacteria in swine-house dust and acute inflammatory reactions in humans. Am J Respir Crit Care Med 1996; 154:1261-6.
29. Alexis NE, Lay JC, Almond M, Peden DB. Inhalation of low-dose endotoxin favors local T(H)2 response and primes airway phagocytes in vivo. J Allergy Clin Immunol 2004; 114:1325-31.
30. Boehlecke B, Hazucha M, Alexis NE et al. Low-dose airborne endotoxin exposure enhances bronchial responsiveness to inhaled allergen in atopic asthmatics. J Allergy Clin Immunol 2003; 112:1241-3.
31. Alexis NE, Lay JC, Almond M, Bromberg PA, Patel DD, Peden DB. Acute LPS inhalation in healthy volunteers induces dendritic cell maturation in vivo. J Allergy Clin Immunol 2005; 115:345-50.
32. Schaumann F, Muller M, Braun A et al. Endotoxin augments myeloid dendritic cell influx into the airways in patients with allergic asthma. Am J Respir Crit Care Med 2008; 177:1307-13.
33. Sohy C, Pons F, Casset A et al. Low-dose endotoxin in allergic asthmatics: effect on bronchial and inflammatory response to cat allergen. Clin Exp Allergy 2006; 36:795-802.
34. Dabbagh K, Dahl ME, Stepick-Biek P, Lewis DB. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J Immunol 2002; 168:4524-30.
35. Hollingsworth JW, Whitehead GS, Lin KL et al. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol 2006; 176:5856-62.
36. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196:1645-51.
37. Gerhold K, Blumchen K, Bock A et al. Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 2002; 110:110-6.
38. Gerhold K, Avagyan A, Reichert E, Blumchen K, Wahn U, Hamelmann E. Lipopolysaccharides modulate allergen-specific immune regulation in a murine model of mucosal tolerance induction. Int Arch Allergy Immunol 2008; 147:25-34.
39. Delayre-Orthez C, Becker J, de Blay F, Frossard N, Pons F. Exposure to endotoxins during sensitization prevents further endotoxin-induced exacerbation of airway inflammation in a mouse model of allergic asthma. Int Arch Allergy Immunol 2005; 138:298-304.
40. Bortolatto J, Borducchi E, Rodriguez D et al. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/ interferon-gamma axis. Clin Exp Allergy 2008; 38:1668-79.
41. Komlosi ZI, Pozsonyi E, Tabi T et al. Lipopolysaccharide exposure makes allergic airway inflammation and hyper-responsiveness less responsive to dexamethasone and inhibition of iNOS. Clin Exp Allergy 2006; 36:951-9.
42. Rodriguez D, Keller AC, Faquim-Mauro EL et al. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 2003; 171:1001-8.
43. Murakami D, Yamada H, Yajima T, Masuda A, Komune S, Yoshikai Y. Lipopolysaccharide inhalation exacerbates allergic airway inflammation by activating mast cells and promoting Th2 responses. Clin Exp Allergy 2007; 37:339-47.
44. Piggott DA, Eisenbarth SC, Xu L et al. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J Clin Invest 2005; 115:459-67.
45. Kim YK, Oh SY, Jeon SG et al. Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol 2007; 178:5375-82.
46. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160:1532-9.
47. Kim YS, Hong SW, Choi JP et al. Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. J Immunol 2009; 183:5113-20.
48. Cochran JR, Khan AM, Elidemir O et al. Influence of lipopolysaccharide exposure on airway function and allergic responses in developing mice. Pediatr Pulmonol 2002; 34:267-77.
49. Wang Y, McCusker C. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J Allergy Clin Immunol 2006; 118:143-51.
50. Gerhold K, Bluemchen K, Franke A, Stock P, Hamelmann E. Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J Allergy Clin Immunol 2003; 112:389-96.
51. Gerhold K, Avagyan A, Seib C et al. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J Allergy Clin Immunol 2006; 118:666-73.
52. Blumer N, Herz U, Wegmann M, Renz H. Prenatal lipopolysaccharide-exposure prevents allergic sensitization and airway inflammation, but not airway responsiveness in a murine model of experimental asthma. Clin Exp Allergy 2005; 35:397-402.
53. Williams KL. Microbial biodiversity and lipopolysaccharide heterogeneity: from static to dynamic modelsendotoxins: pyrogens, LAL testing and depyrogenation. New York: Informa Healthcare, 2007; 111-31.
54. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001; 167:5067-76.
55. Tanamoto K, Azumi S, Haishima Y, Kumada H, Umemoto T. The lipid A moiety of porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice. J Immunol 1997; 158:4430-6.
56. Kumada H, Haishima Y, Watanabe K et al. Biological properties of the native and synthetic lipid A of porphyromonas gingivalis lipopolysaccharide. Oral Microbiol Immunol 2008; 23:60-9.
57. Codolo G, Mazzi P, Amedei A et al. The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell Microbiol 2008; 10:2355-63.
58. Revets H, Pynaert G, Grooten J, De Baetselier P, Lipoprotein I. a TLR2/4 ligand modulates Th2-driven allergic immune responses. J Immunol 2005; 174:1097-103.
59. Ng N, Lam D, Paulus P, Batzer G, Horner AA. House dust extracts have both TH2 adjuvant and tolerogenic activities. J Allergy Clin Immunol 2006; 117:1074-81.
60. Lam D, Ng N, Lee S, Batzer G, Horner AA. Airway house dust extract exposures modify allergen-induced airway hypersensitivity responses by TLR4-dependent and independent pathways. J Immunol 2008; 181:2925-32.
61. Wikstrom ME, Batanero E, Smith M et al. Influence of mucosal adjuvants on antigen passage and CD4+T cell activation during the primary response to airborne allergen. J Immunol 2006; 177:913-24.
62. Duan W, So T, Croft M. Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+T regulatory cells. J Immunol 2008; 181:8650-9.
63. Nigo YI, Yamashita M, Hirahara K et al. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc Natl Acad Sci U S A 2006; 103:2286-91.
64. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999; 54:825-57.
65. Macatonia SE, Hosken NA, Litton M et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+T cells. J Immunol 1995; 154:5071-9.
66. Boguniewicz M, Schneider LC, Milgrom H et al. Treatment of steroid-dependent asthma with recombinant interferon-gamma. Clin Exp Allergy 1993; 23:785-90.
67. Bryan SA, O'Connor BJ, Matti S et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356:2149-53.